Announcements

Director Kevin P. Clark filed a Form 4 with the SEC on September 10, 2026, disclosing the sale of 122,722 ordinary shares of Versigent PLC (NASDAQ:VGNT) across six transactions on September 8 and 9, 2026, pursuant to a Rule 10b5-1 trading plan.

A Form 4 filed with the SEC on September 10, 2026 discloses that Ray Stata, a director of Analog Devices Inc (NASDAQ:ADI), sold a total of 2,632 shares of common stock across eleven transactions on September 8 and September 9, 2026, pursuant to a …

A Form 4 filed on September 10, 2026, reports that Gregory McLaughlin, a director of Realty Income Corp (NYSE:O), sold 3,475 shares of common stock held indirectly through a family trust on September 10, 2026.

A Form 4 filed on September 10, 2026 discloses that Joshua Hug, a director of Remitly Global, Inc. (NASDAQ:RELY), sold a total of 11,000 shares of common stock on September 8 and September 9, 2026, under a pre-established Rule 10b5-1 trading plan.

A statement of changes in beneficial ownership for Eric Vishria, a director at Cerebras Systems Inc., was filed with the SEC on September 10, 2026, disclosing a transaction dated September 8, 2026.

Denise Kulikowsky, Chief People Officer of Tapestry, Inc., filed a Form 4 with the SEC on September 10, 2026, reporting a series of transactions in Tapestry common stock dated September 9, 2026, including a stock option exercise and subsequent share disposals.

A Form 4 filed on September 10, 2026 with the U.S. Securities and Exchange Commission disclosed that Joseph Truitt, a newly appointed director of Century Therapeutics, Inc. (NASDAQ:IPSC), was granted 148,000 stock options on September 9, 2026 in connection with his appointment to the …